NCT06953830
Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrolling by Invitation
NAAges 18+InterventionalDiagnosticWilliam Jennings Bryan Dorn VA Medical CenterGovernment-funded
~100 participants
Updated 2025-05-01 on ClinicalTrials.gov
What's tested:Vibration-controlled transient elastography
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Spleen Stiffness measurement
Measured over 1 year
Conditions
Where it's being run
1 sites across 1 statesSouth Carolina1
Study leadership
- Nicholas Hoppmann, MD · PRINCIPAL_INVESTIGATOR · Columbia VA Healthcare System
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Able to consent for participation in a clinical study
Able to read and comprehend English
Evidence of fatty liver disease on previous liver biopsy, imaging or clinical documentation
Exclusion
Pregnant
Known decompensated cirrhosis or hepatocellular carcinoma
Absence of spleen
Documentation of alcohol use disorder or alcohol use greater than 20g/day for women or greater than 30 g/day for men
Unable to provide informed consent
What this trial measures
- Spleen Stiffness measurement1 year
Percent of participants with valid spleen stiffness measurements using vibration controlled transient elastography